熱門資訊> 正文
INVO Bioscience申请1亿美元混合货架
2024-05-22 04:52
- INVO Bioscience (NASDAQ:INVO) on Tuesday filed a prospectus for a mixed securities shelf offering of up to $100M.
- This prospectus is not an offer to sell these securities.
- SEC Filing
More on INVO BioScience
- Seeking Alpha’s Quant Rating on INVO BioScience
- Historical earnings data for INVO BioScience
- Financial information for INVO BioScience
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。